E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/12/2021 in the Prospect News Investment Grade Daily.

New Issue: LabCorp sells $1 billion senior notes in two tranches due 2026, 2031

By Cristal Cody

Chicago, May 12 – Laboratory Corp. of America Holdings sold $1 billion of senior notes (Baa2) in two parts on Wednesday, according to a market source.

Each tranche was sized at $500 million.

The issuer sold 1.55% notes due June 1, 2026 at Treasuries plus 70 basis points, tighter than talk in the Treasuries plus 95 bps to 100 bps area.

A 10-year tranche was sold with a 2.7% coupon and a Treasuries plus 105 bps spread, similarly tighter than talk in the 125 bps to 130 bps area.

BofA Securities, Inc., KeyBanc Capital Markets Inc. and Wells Fargo Securities, LLC are the joint bookrunners.

The company plans to use proceeds to redeem its outstanding 3.2% senior notes due Feb. 1, 2022 and 3.75% senior notes due Aug. 23, 2022 prior to their respective maturities, according to a press release.

Based in Burlington, N.C., LabCorp provides comprehensive clinical laboratory and end-to-end drug development services.

Issuer:Laboratory Corp. of America Holdings
Issue:Senior notes
Amount:$1 billion
Bookrunners:BofA Securities, Inc., KeyBanc Capital Markets Inc. and Wells Fargo Securities, LLC
Trade date:May 12
Settlement date:May 26
Rating:Moody’s: Baa2
2026 notes
Amount:$500 million
Maturity:June 1, 2026
Coupon:1.55%
Spread:Treasuries plus 70 bps
Price talk:Treasuries plus 95 to 100 bps area
2031 notes
Amount:$500 million
Maturity:June 1, 2031
Coupon:2.7%
Spread:Treasuries plus 105 bps
Price talk:Treasuries plus 125 bps to 130 bps area

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.